國立虎尾科技大學 |

Nuclear Receptors = The Art and Science of Modulator Design and Discovery /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Nuclear Receptors/ edited by Mostafa Z. Badr.
其他題名:	The Art and Science of Modulator Design and Discovery /
其他作者:	Badr, Mostafa Z.
面頁冊數:	XI, 679 p. 209 illus., 127 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Medical Biochemistry. -
電子資源:	https://doi.org/10.1007/978-3-030-78315-0
ISBN:	9783030783150

Nuclear Receptors = The Art and Science of Modulator Design and Discovery /
Nuclear ReceptorsThe Art and Science of Modulator Design and Discovery /[electronic resource] :edited by Mostafa Z. Badr. - 1st ed. 2021. - XI, 679 p. 209 illus., 127 illus. in color.online resource.

1. Molecular Pharmacology of the Youngest Member of the Nuclear Receptor Family: The Mineralocorticoid Receptor -- 2. A Simple Method for Visual Assessment and Quantification of Altered Subcellular Localization of Nuclear Receptors -- 3. Multifaceted Effects of Ligand on Nuclear Receptor Mobility -- 4. Chemical Considerations in Discovery of Receptor Modulators -- 5. Structure-Based Design of Estrogen-Related Receptors Modulators -- 6. PPARα and δ ligand design – Honing the traditional empirical method with a more holistic overview -- 7. Pregnane X Receptor: understanding its function and activity at the molecular level -- 8. Ligand Design for the Vitamin D Receptor -- 9. What Makes a Good Antagonist: Lessons Learned from the Estrogen and Aryl Hydrocarbon Receptors -- 10. Design of Novel PPAR agonist for Neurodegenerative Disease -- 11. Functional bioassays lithograph ligand reflections in the PPARalpha sphere -- 12. Computational applications on Food Contact Chemicals as Nuclear Receptors binders -- 13. Alternation of Nuclear Hormone Receptor Signaling by Antiviral Drugs -- 14. Retinoic acid-related orphan receptor (ROR) inverse agonists: potential therapeutic strategies for multiple inflammatory diseases -- 15. Therapeutic Strategies to Target Activating Estrogen Receptor a Mutation -- 16. Androgen Receptors in the Pathology of Disease -- 17. Bilirubin: A Ligand of the PPARα Nuclear Receptor -- 18. Nuclear Receptor Ligands in Flavivirus Infection Control -- 19. Use of Nanotechnology to Improve 15d-PGJ2 Immunomodulatory Activities -- 20.Ligand-independent Activation of PPARs -- 21. PPAR Modulation Through Posttranslational Modification Control -- 22. Developing Inhibitors to the Amino-Terminus Domains of Steroid Hormone Receptors -- 23. Redirecting the cellular waste disposal machinery to target transcription.

Nuclear receptors are ligand activated transcription factors that control numerous biological functions. Consequently, altering activity of these receptors is proposed, and indeed documented, to affect many physiological and pathological conditions in experimental animals and humans. Thus, nuclear receptors have become a major target in the effort to treat numerous diseases. This book will shed light on and emphasize intricate processes involved in designing as well as discovering physiological and pharmacological modulators of these important proteins. World-renowned scientists will share with the reader their professional expertise and extensive experience acquired through decades working with nuclear receptors. Chapters address the various means and consequences of modulating nuclear receptor activity will be presented and discussed. These modulators cover a wide span of moieties ranging from synthetic chemicals to natural products. In addition, the classification of these chemicals ranges from pan agonists to selective agonists and inverse agonists to antagonists. They also include proteolytic means to obliterate the receptor in the event that modulating its activity through canonical pharmacological agents becomes less effective and/or less desirable due to anticipated or experienced toxicities. Modulation of receptor activity may also take place in the absence of a ligand or through manipulating the structure of the receptor itself by controlling posttranslational events.

ISBN: 9783030783150

Standard No.: 10.1007/978-3-030-78315-0doiSubjects--Topical Terms:

668897
Medical Biochemistry.

LC Class. No.: RC261-271

Dewey Class. No.: 614.5999

Nuclear Receptors = The Art and Science of Modulator Design and Discovery /
LDR:04748nam a22003975i 4500 001 1053077
003 DE-He213
005 20210928212522.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030783150 $9 978-3-030-78315-0
024 7 $a 10.1007/978-3-030-78315-0 $2 doi
035 $a 978-3-030-78315-0
050 4 $a RC261-271
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
245 1 0 $a Nuclear Receptors $h [electronic resource] : $b The Art and Science of Modulator Design and Discovery / $c edited by Mostafa Z. Badr.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XI, 679 p. 209 illus., 127 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Molecular Pharmacology of the Youngest Member of the Nuclear Receptor Family: The Mineralocorticoid Receptor -- 2. A Simple Method for Visual Assessment and Quantification of Altered Subcellular Localization of Nuclear Receptors -- 3. Multifaceted Effects of Ligand on Nuclear Receptor Mobility -- 4. Chemical Considerations in Discovery of Receptor Modulators -- 5. Structure-Based Design of Estrogen-Related Receptors Modulators -- 6. PPARα and δ ligand design – Honing the traditional empirical method with a more holistic overview -- 7. Pregnane X Receptor: understanding its function and activity at the molecular level -- 8. Ligand Design for the Vitamin D Receptor -- 9. What Makes a Good Antagonist: Lessons Learned from the Estrogen and Aryl Hydrocarbon Receptors -- 10. Design of Novel PPAR agonist for Neurodegenerative Disease -- 11. Functional bioassays lithograph ligand reflections in the PPARalpha sphere -- 12. Computational applications on Food Contact Chemicals as Nuclear Receptors binders -- 13. Alternation of Nuclear Hormone Receptor Signaling by Antiviral Drugs -- 14. Retinoic acid-related orphan receptor (ROR) inverse agonists: potential therapeutic strategies for multiple inflammatory diseases -- 15. Therapeutic Strategies to Target Activating Estrogen Receptor a Mutation -- 16. Androgen Receptors in the Pathology of Disease -- 17. Bilirubin: A Ligand of the PPARα Nuclear Receptor -- 18. Nuclear Receptor Ligands in Flavivirus Infection Control -- 19. Use of Nanotechnology to Improve 15d-PGJ2 Immunomodulatory Activities -- 20.Ligand-independent Activation of PPARs -- 21. PPAR Modulation Through Posttranslational Modification Control -- 22. Developing Inhibitors to the Amino-Terminus Domains of Steroid Hormone Receptors -- 23. Redirecting the cellular waste disposal machinery to target transcription.
520 $a Nuclear receptors are ligand activated transcription factors that control numerous biological functions. Consequently, altering activity of these receptors is proposed, and indeed documented, to affect many physiological and pathological conditions in experimental animals and humans. Thus, nuclear receptors have become a major target in the effort to treat numerous diseases. This book will shed light on and emphasize intricate processes involved in designing as well as discovering physiological and pharmacological modulators of these important proteins. World-renowned scientists will share with the reader their professional expertise and extensive experience acquired through decades working with nuclear receptors. Chapters address the various means and consequences of modulating nuclear receptor activity will be presented and discussed. These modulators cover a wide span of moieties ranging from synthetic chemicals to natural products. In addition, the classification of these chemicals ranges from pan agonists to selective agonists and inverse agonists to antagonists. They also include proteolytic means to obliterate the receptor in the event that modulating its activity through canonical pharmacological agents becomes less effective and/or less desirable due to anticipated or experienced toxicities. Modulation of receptor activity may also take place in the absence of a ligand or through manipulating the structure of the receptor itself by controlling posttranslational events.
650 2 4 $a Medical Biochemistry. $3 668897
650 1 4 $a Cancer Research. $3 668358
650 0 $a Medical biochemistry. $3 1254555
650 0 $a Cancer research. $3 1253664
700 1 $a Badr, Mostafa Z. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1075629
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030783143
776 0 8 $i Printed edition: $z 9783030783167
776 0 8 $i Printed edition: $z 9783030784386
856 4 0 $u https://doi.org/10.1007/978-3-030-78315-0
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)